Cambrex is an innovative life sciences company with a refreshingly human approach to the way we do business. Our pharmaceutical products, technologies and expertise accelerate your small molecule therapeutics into the market.Learn more
Cambrex has announced it has completed the acquisition of Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO) located in Whippany, New Jersey and Mirabel, Québec, Canada, for approximately $425 million. The addition of the facilities adds formulation development and finished dosage manufacturing capabilities to Cambrex’s existing global API manufacturing network.Learn more
Active Pharmaceutical Ingredients and dynamic people come together to create the Cambrex effect. Watch our video to learn how we can accelerate your small molecule therapeutics into the market.
Cambrex is a leading global supplier of more than 90 generic APIs.
With API R&D and cGMP facilities in the USA and Europe, Cambrex can support your project in regulated, emerging and developing markets. We are in your neighbourhood, wherever you are.See our facilities